New T-cell therapy could provide universal cancer treatment

Researchers have discovered a new type of T-cell receptor that can kill most cancer types while leaving healthy cells unharmed.

Frontiers Advances in Universal CAR-T Cell Therapy

Chimeric Antigen Receptor Therapy

Promises and challenges of adoptive T-cell therapies for solid tumours

Who are the leading innovators in cancer chimeric antigen receptor (CAR) T-cell therapy for the pharmaceutical industry?

Frontiers The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook

Tumor buster - where will the CAR-T cell therapy 'missile' go?, Molecular Cancer

News - Page 168 of 425 - Drug Target Review

Study Reveals New Insights Into Immune System Role in Lung Cancer Risk

Clinical implications of T cell exhaustion for cancer immunotherapy

Cardiff University - News, Articles, Whitepapers - Drug Target Review

CAR T-cell therapy experts push boundaries of pediatric cancer treatment, Cancer, Pediatrics

Frontiers Paving the Way Towards Universal Chimeric Antigen Receptor Therapy in Cancer Treatment: Current Landscape and Progress

Cardiff University - News, Articles, Whitepapers - Drug Target Review